Baxter International Inc
Veridion Score
Composite trend over time
Why is BAX moving today?
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for BAX.
BAX insider activity
Baxter International Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$2.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-02 | Wallace Steven P. | Insider | sell | $18.68 | 153 | 70,128 | $3K | SEC Form 4 |
| 2026-06-03 | 2026-06-02 | Teaff James | Insider | sell | $18.68 | 321 | 31,063 | $6K | SEC Form 4 |
| 2026-03-10 | 2026-03-06 | Zielinski Anita A | Insider | sell | $17.69 | 1,932 | 46,281 | $34K | SEC Form 4 |
| 2026-03-10 | 2026-03-06 | Soriano Maria Cecilia | Insider | sell | $17.69 | 2,848 | 75,045 | $50K | SEC Form 4 |
| 2026-03-10 | 2026-03-06 | Rosenbloom David S. | Insider | sell | $17.69 | 6,620 | 138,216 | $117K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 14 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moBAX contract awards, year to date.
Public federal awards linked to this ticker.
BAX lobbying filings, year to date.
Registered lobbying filings matched to Baxter International Inc.